Triple-Negative Breast Cancer
Triple-Negative Breast Cancer
复制标题
DOI：
10.1007/978-3-319-60336-0_11
复制
发表时间：
2018
期刊：
影响因子：
--
通讯作者：
T. Avery
中科院分区：
文献类型：
--
作者：
T. Avery
三阴性乳腺癌（TNBC）是一种侵袭性乳腺癌，在流行病学，风险因素和预后方面与其他类型的乳腺癌不同。治疗TNBC的挑战在于缺乏目前可用的靶向疗法。化疗仍然是目前唯一的治疗选择。目前的研究工作集中在确定靶向药物和优化TNBC的治疗。TNBC的不同分子亚型的鉴定可能有助于进一步定制这种类型乳腺癌的治疗。
Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer that differs in epidemiology, risk factors, and prognosis from other types of breast cancer. The challenge in treating TNBC lies in the lack of targeted therapies currently available. Chemotherapy remains the only treatment option presently. Current research efforts are focused on identifying targeted agents and optimizing treatment for TNBC. Identification of different molecular subtypes of TNBC may aid in further tailoring treatment for this type of breast cancer.